세계의 알부민 시장 보고서(2025년)

Albumin is a type of protein present in blood plasma, serum, muscle, egg whites, milk, and other animal substances, as well as in various plant tissues and fluids. It is a simple protein that is heat-coagulable and water-soluble, playing a vital role in maintaining fluid balance and transporting hormones, vitamins, and enzymes throughout the body.

The primary types of albumin are human serum albumin, bovine serum albumin, and recombinant serum albumin. Human serum albumin, found in blood plasma, helps maintain osmotic pressure and transports various substances such as hormones and fatty acids. Its applications include therapeutics, drug formulation, vaccines, and media components, distributed through channels such as business-to-customer (B2C) and business-to-business (B2B). The end users of albumin include hospitals and clinics, pharmaceutical and biotechnology companies, and research institutes.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The albumin research report is one of a series of new reports from The Business Research Company that provides albumin market statistics, including the albumin industry's global market size, regional shares, competitors with an albumin market share, detailed albumin market segments, market trends and opportunities, and any further data you may need to thrive in the albumin industry. This albumin market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The albumin market size has grown strongly in recent years. It will grow from $6.57 billion in 2024 to $7.16 billion in 2025 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to advancements in biotechnology, increased demand for plasma-derived therapies, expanding applications in pharmaceuticals, high prevalence of liver diseases, regulatory approvals for albumin-based products, and globalization of healthcare leading to wider market access.

The albumin market size is expected to see strong growth in the next few years. It will grow to $9.93 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to the increasing prevalence of liver diseases, expanding applications in regenerative medicine, rising geriatric population, evolving diagnostic techniques, shifting healthcare infrastructure towards outpatient care, and growing awareness about the importance of maintaining optimal protein levels. Major trends in the forecast period include expanding therapeutic applications, rising adoption in drug delivery systems, increasing demand in cell culture media, growth in personalized medicine, advancements in recombinant technology, heightened awareness of hypoalbuminemia treatment, and significant investment in research and development for innovative albumin-based products.

The forecast of 8.5% growth over the next five years reflects a modest reduction of 0.5% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. healthcare system by increasing the cost of human serum albumin products and plasma protein solutions sourced from Austria and China, thereby straining critical care supplies and elevating hospital pharmacy expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of diabetes is poised to drive growth in the albumin market moving forward. Diabetes, a metabolic disorder characterized by prolonged high blood sugar levels, is on the rise due to factors such as poor nutrition, sedentary lifestyles, hormonal conditions, and obesity. Albumin plays a critical role in diabetes management as a significant biomarker, guiding insulin therapy, monitoring glycemic control, aiding diagnosis, and predicting complications such as diabetic ketoacidosis (DKA). Maintaining normal albumin levels is crucial for effectively managing diabetes. According to the National Library of Medicine, global diabetes prevalence was estimated at 10.5% in 2021, affecting approximately 536.6 million individuals aged 20-79 years. Projections suggest this figure could reach 12.2% by 2045, impacting about 783.2 million people. Therefore, the rising incidence of diabetes is expected to drive growth in the albumin market.

Leading companies in the albumin market are focusing on innovation, developing products such as animal- and human-origin-free recombinant albumin to meet increasing demand with advanced features. This type of albumin is produced using non-mammalian expression systems such as yeast and does not contain any animal- or human-derived components. For example, in March 2023, Albumedix, a UK-based manufacturer of recombinant human albumin (rHA), collaborated with Heartseed Inc., a Japan-based clinical-stage biotech company, to introduce Recombin as a critical excipient for Heartseed's investigational cell therapy, HS-001, during its first-in-human clinical trial. This partnership represents a significant milestone in advancing HS-001, promising innovative treatment approaches for various diseases. The use of recombinant technology ensures optimal performance and stability of the cell therapy, enhancing its potential for therapeutic success.

In September 2022, Sartorius AG, a Germany-based supplier of pharmaceutical and laboratory equipment, acquired Albumedix, strengthening its position in the expanding sector of advanced therapies and vaccines. This acquisition aligns Albumedix's innovative recombinant albumin technology with Sartorius' portfolio of cell culture media and process solutions, bolstering the company's offerings in the dynamic market landscape of advanced therapies. Albumedix Ltd. is a UK-based provider of high-quality recombinant human albumin solutions.

Major companies operating in the albumin market are Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Takeda Pharmaceutical Company Limited, Merck KGaA, Baxter International Inc., CSL Limited, Grifols SA, Mitsubishi Tanabe Pharma Corporation, Octapharma AG, Kedrion S.p.A., Biotest AG, Jiangxi Boya Bio-Pharmaceutical Co. Ltd., BPL (Bio Products Laboratory), Kamada Ltd., Proliant Biologicals, SeraCare Life Sciences Inc., HiMedia Laboratories, Albumedix Ltd., Medxbio Pte Ltd., Ventria Bioscience Inc., China Biologic Products Holdings Inc.

North America was the largest region in the albumin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the albumin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the albumin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The albumin market consists of sales of egg albumin, plant-based albumin, and recombinant human albumin. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Albumin Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on albumin market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for albumin ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The albumin market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Human Serum Albumin; Bovine Serum Albumin; Recombinant Albumin
• 2) By Application: Therapeutics; Drug Formulation And Vaccines; Component Of Media; Other Applications
• 3) By Sales Channel: Business-To-Consumer (B2C); Business-To-Business (B2B)
• 4) By End-User: Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Research Institutes
• Subsegments:
• 1) By Human Serum Albumin: Plasma-Derived Human Serum Albumin; Recombinant Human Serum Albumin; Human Serum Albumin For Therapeutic Use (In Liver Disease, Burns); Human Serum Albumin For Drug Delivery And Research Applications
• 2) By Bovine Serum Albumin: Bovine Serum Albumin For Laboratory Use (In Cell Culture); Bovine Serum Albumin For Diagnostic Kits; Bovine Serum Albumin As A Stabilizer In Vaccines And Biopharmaceuticals
• 3) By Recombinant Albumin: Recombinant Human Albumin For Therapeutic Applications; Recombinant Albumin For Biopharmaceutical Formulation; Recombinant Albumin For Cosmetic And Personal Care Applications; Recombinant Albumin For Research And Diagnostic Applications
• Companies Mentioned: Bristol-Myers Squibb Company; Thermo Fisher Scientific Inc.; Takeda Pharmaceutical Company Limited; Merck KGaA; Baxter International Inc.; CSL Limited; Grifols SA; Mitsubishi Tanabe Pharma Corporation; Octapharma AG; Kedrion S.p.A.; Biotest AG; Jiangxi Boya Bio-Pharmaceutical Co. Ltd.; BPL (Bio Products Laboratory); Kamada Ltd.; Proliant Biologicals; SeraCare Life Sciences Inc.; HiMedia Laboratories; Albumedix Ltd.; Medxbio Pte Ltd.; Ventria Bioscience Inc.; China Biologic Products Holdings Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Albumin Market Characteristics

3. Albumin Market Trends And Strategies

4. Albumin Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Albumin Growth Analysis And Strategic Analysis Framework

• 5.1. Global Albumin PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Albumin Market Growth Rate Analysis
• 5.4. Global Albumin Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Albumin Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Albumin Total Addressable Market (TAM)

6. Albumin Market Segmentation

• 6.1. Global Albumin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Human Serum Albumin
• Bovine Serum Albumin
• Recombinant Albumin
• 6.2. Global Albumin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Therapeutics
• Drug Formulation And Vaccines
• Component Of Media
• Other Applications
• 6.3. Global Albumin Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Business-To-Consumer (B2C)
• Business-To-Business (B2B)
• 6.4. Global Albumin Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Pharmaceutical And Biotechnology Companies
• Research Institutes
• 6.5. Global Albumin Market, Sub-Segmentation Of Human Serum Albumin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Plasma-Derived Human Serum Albumin
• Recombinant Human Serum Albumin
• Human Serum Albumin For Therapeutic Use (In Liver Disease, Burns)
• Human Serum Albumin For Drug Delivery And Research Applications
• 6.6. Global Albumin Market, Sub-Segmentation Of Bovine Serum Albumin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bovine Serum Albumin For Laboratory Use (In Cell Culture)
• Bovine Serum Albumin For Diagnostic Kits
• Bovine Serum Albumin As A Stabilizer In Vaccines And Biopharmaceuticals
• 6.7. Global Albumin Market, Sub-Segmentation Of Recombinant Albumin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Recombinant Human Albumin For Therapeutic Applications
• Recombinant Albumin For Biopharmaceutical Formulation
• Recombinant Albumin For Cosmetic And Personal Care Applications
• Recombinant Albumin For Research And Diagnostic Applications

7. Albumin Market Regional And Country Analysis

• 7.1. Global Albumin Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Albumin Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Albumin Market

• 8.1. Asia-Pacific Albumin Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Albumin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Albumin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Albumin Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Albumin Market

• 9.1. China Albumin Market Overview
• 9.2. China Albumin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Albumin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Albumin Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Albumin Market

• 10.1. India Albumin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Albumin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Albumin Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Albumin Market

• 11.1. Japan Albumin Market Overview
• 11.2. Japan Albumin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Albumin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Albumin Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Albumin Market

• 12.1. Australia Albumin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Albumin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Albumin Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Albumin Market

• 13.1. Indonesia Albumin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Albumin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Albumin Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Albumin Market

• 14.1. South Korea Albumin Market Overview
• 14.2. South Korea Albumin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Albumin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Albumin Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Albumin Market

• 15.1. Western Europe Albumin Market Overview
• 15.2. Western Europe Albumin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Albumin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Albumin Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Albumin Market

• 16.1. UK Albumin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Albumin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Albumin Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Albumin Market

• 17.1. Germany Albumin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Albumin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Albumin Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Albumin Market

• 18.1. France Albumin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Albumin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Albumin Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Albumin Market

• 19.1. Italy Albumin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Albumin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Albumin Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Albumin Market

• 20.1. Spain Albumin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Albumin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Albumin Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Albumin Market

• 21.1. Eastern Europe Albumin Market Overview
• 21.2. Eastern Europe Albumin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Albumin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Albumin Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Albumin Market

• 22.1. Russia Albumin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Albumin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Albumin Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Albumin Market

• 23.1. North America Albumin Market Overview
• 23.2. North America Albumin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Albumin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Albumin Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Albumin Market

• 24.1. USA Albumin Market Overview
• 24.2. USA Albumin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Albumin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Albumin Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Albumin Market

• 25.1. Canada Albumin Market Overview
• 25.2. Canada Albumin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Albumin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Albumin Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Albumin Market

• 26.1. South America Albumin Market Overview
• 26.2. South America Albumin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Albumin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Albumin Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Albumin Market

• 27.1. Brazil Albumin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Albumin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Albumin Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Albumin Market

• 28.1. Middle East Albumin Market Overview
• 28.2. Middle East Albumin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Albumin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Albumin Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Albumin Market

• 29.1. Africa Albumin Market Overview
• 29.2. Africa Albumin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Albumin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Albumin Market, Segmentation By Sales Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Albumin Market Competitive Landscape And Company Profiles

• 30.1. Albumin Market Competitive Landscape
• 30.2. Albumin Market Company Profiles
  • 30.2.1. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Albumin Market Other Major And Innovative Companies

• 31.1. CSL Limited
• 31.2. Grifols SA
• 31.3. Mitsubishi Tanabe Pharma Corporation
• 31.4. Octapharma AG
• 31.5. Kedrion S.p.A.
• 31.6. Biotest AG
• 31.7. Jiangxi Boya Bio-Pharmaceutical Co. Ltd.
• 31.8. BPL (Bio Products Laboratory)
• 31.9. Kamada Ltd.
• 31.10. Proliant Biologicals
• 31.11. SeraCare Life Sciences Inc.
• 31.12. HiMedia Laboratories
• 31.13. Albumedix Ltd.
• 31.14. Medxbio Pte Ltd.
• 31.15. Ventria Bioscience Inc.

32. Global Albumin Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Albumin Market

34. Recent Developments In The Albumin Market

35. Albumin Market High Potential Countries, Segments and Strategies

• 35.1 Albumin Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Albumin Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Albumin Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer